Aciclovir-induced neurotoxicity: Utility of CSF and serum CMMG levels in diagnosis
Authors:
- 1 December 2014
- journal article
- case report
- Published by Elsevier in Journal of Clinical Virology
- Vol. 61 (4) , 608-610
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Pharmacokinetics of Acyclovir and Its Metabolites in Cerebrospinal Fluid and Systemic Circulation after Administration of High-Dose Valacyclovir in Subjects with Normal and Impaired Renal FunctionAntimicrobial Agents and Chemotherapy, 2010
- The aciclovir metabolite CMMG is detectable in the CSF of subjects with neuropsychiatric symptoms during aciclovir and valaciclovir treatmentJournal of Antimicrobial Chemotherapy, 2006
- High serum concentrations of the acyclovir main metabolite 9-carboxymethoxymethylguanine in renal failure patients with acyclovir-related neuropsychiatric side effects: an observational studyNephrology Dialysis Transplantation, 2003
- Coma secondary to aciclovir neurotoxicityIrish Journal of Medical Science (1971 -), 2001
- Crystal-induced acute renal failureThe American Journal of Medicine, 1999
- Distinguishing acyclovir neurotoxicity from encephalomyelitisJournal of Internal Medicine, 1993
- Adverse Effects of High-Dose Intravenous Acyclovir in Ambulatory Patients with Acute Herpes ZosterThe Journal of Infectious Diseases, 1985